eft ventricular (LV) systolic 1 and diastolic 2,3 functions are frequently impaired in hypertensive patients with LV hypertrophy. Because LV hypertrophy may become an important risk factor increasing the morbidity or mortality in ischemic heart disease, 4,5 many clinical studies have been conducted to evaluate morphological and functional improvements of the LV after administering various antihypertensive drugs. [6][7][8][9] Conversely, a number of studies on LV diastolic function in hypertensive patients show that diastolic dysfunction occurs before LV hypertrophy or systolic dysfunction. 2,3,10 Parameters obtained from the transmitral flow velocity pattern correlated closely with parameters obtained by left ventriculography 11 and radionuclide angiography. 12 Therefore, the transmitral flow velocity pattern is widely used to evaluate LV diastolic function in clinical settings. However, because the transmitral flow velocity pattern is influenced strongly by loading condition, such as left atrial pressure or aortic pressure, there is a limitation when this index is used to evaluate LV diastolic Japanese Circulation Journal Vol. 65, April 2001 function in patients with elevated LV end-diastolic pressure. 13,14 Recently, a tissue Doppler imaging (TDI) method has been developed in which large Doppler signals obtained from the ventricular wall can be selectively displayed as a color or pulsed Doppler image by eliminating small Doppler signals produced by the blood flow. This new technique is expected to provide valuable information on LV wall motion abnormalities in patients with heart disease. [15][16][17] Cilnidipine is a novel and unique 1,4-dihydropyridine derivative calcium antagonist that has a hypotensive action of slow-onset and prolonged duration, and has potent inhibitory action on L-and N-type voltage-dependent calcium channels. Clinical usefulness of this calcium antagonist is expected as a result from its heart-protecting action in addition to its antihypertensive effect. 18,19 The present study was designed to evaluate the effect of cilnidipine on LV diastolic dysfunction in hypertensive patients, and to confirm the presence or absence of its beneficial effect.
Methods
Study PopulationThe study comprised 35 Japanese outpatients (19 men and 16 women aged 65±10 years (mean ± SD)) with essential hypertension who had not been treated previously with antihypertensive drugs. All the patients had a systolic blood The purpose of the present study was to examine the mechanisms of improvement in left ventricular (LV) diastolic function in hypertensive patients treated with cilnidipine, a new and unique calcium antagonist that has both L-type and N-type voltage-dependent calcium channel blocking actions, using pulsed Doppler echocardiography and pulsed tissue Doppler imaging. The study comprised 35 untreated patients with essential hypertension (19 men and 16 women; mean age 65±10 years). The peak early diastolic and atrial systolic transmitral flow velocities (E and A, respectively) and their ratio (E/A), and...